TP53 and cancer: Thus, the mutations that perturb ARF/p53-module functions in Msh2−/− MEFs included base substitutions in the p53 DBD and chromosomal deletion at the Cdkn2a gene locus, analogous to those in cancer cells (Supplementary Fig. 5a).